A neurochemically distinct dorsal raphe-limbic circuit with a potential role in affective disorders.
The serotonergic system arising from the dorsal raphe nucleus (DR) has long been implicated in psychiatric disorders, and is considered one site of action of classical anxiolytic and antidepressant agents. Recent studies implicate the DR as a site of action of novel anxiolytic and antidepressant agents that target neuropeptide systems, such as corticotropin-releasing factor (CRF) and neurokinin 1 (NK1) antagonists. The present study identified unique characteristics of the dorsomedial DR that implicate this particular subregion as a key component of a circuit, which may be targeted by these diverse psychotherapeutic agents. First, it was observed that a cluster of CRF-containing cell bodies was present in the dorsomedial DR of colchicine-treated rats. Dual-labeling immunohistochemistry revealed that almost all CRF-containing neurons were serotonergic, implicating CRF as a cotransmitter with serotonin in this subpopulation of DR neurons. Moreover, dendrites laden with immunoreactivity for NK1 had a striking topographic distribution surrounding and extending into the dorsomedial subregion of the DR, suggesting that NK1 receptor ligands may selectively impact the dorsomedial DR. Finally, anterograde tract tracing from the dorsomedial DR combined with CRF immunohistochemistry revealed that CRF-containing axons from this subregion project to CRF-containing neurons of the central nucleus of the amygdala. Taken together, the present results reveal a circuit whereby NK1 receptor activation in the dorsomedial DR can impact on limbic sources of CRF that have been implicated in emotional responses. This circuit may be relevant for understanding the mechanism of action of novel psychotherapeutic agents that act through NK1 or CRF receptors.
Commons
Kathryn G
KG
The Children's Hospital of Philadelphia, Abramson Pediatric Research Center, Philadelphia, PA 19104, USA. commons@email.chop.edu
Connolley
K Ryan
KR
Valentino
Rita J
RJ
D000818:Animals; D003346:Corticotropin-Releasing Hormone / Q000032:analysis; D008032:Limbic System / Q000737:chemistry*; D008297:Male; D019964:Mood Disorders / Q000628:therapy*; D009434:Neural Pathways / Q000737:chemistry; D011903:Raphe Nuclei / Q000737:chemistry*; D051381:Rats; D017207:Rats, Sprague-Dawley; D018040:Receptors, Neurokinin-1 / Q000032:analysis; D012701:Serotonin / Q000032:analysis
D018040:Receptors, Neurokinin-1; D012701:Serotonin; D003346:Corticotropin-Releasing Hormone